Articles

Breakthrough and Accessibility: Boao Lecheng’s Third Batch of Stem Cell Therapies Sets New Standards in Regenerative Medicine

2025-09-02T22:46:47+08:00

Explore the pricing and details of Boao Lecheng's third batch of approved stem cell and gene therapies. Learn about innovative treatments for EBV, pulmonary fibrosis, ovarian insufficiency, and their costs.

Breakthrough and Accessibility: Boao Lecheng’s Third Batch of Stem Cell Therapies Sets New Standards in Regenerative Medicine2025-09-02T22:46:47+08:00

Zemcelpro: Revolutionizing Blood Cancer Treatment Through Innovative Stem Cell Therapy

2025-08-28T23:59:50+08:00

Explore Zemcelpro, the newly EU-approved stem cell therapy for blood cancer patients without donor matches. Learn how ExCellThera's innovative UM171 technology expands cord blood cells to improve transplant outcomes.

Zemcelpro: Revolutionizing Blood Cancer Treatment Through Innovative Stem Cell Therapy2025-08-28T23:59:50+08:00

JointStem and the Future of Regenerative Medicine: A New Hope for Knee Osteoarthritis

2025-08-28T10:31:00+08:00

Explore JointStem, an FDA breakthrough stem cell therapy for knee osteoarthritis. Discover how it regenerates cartilage, reduces pain, and offers a surgery-free alternative to traditional treatments.

JointStem and the Future of Regenerative Medicine: A New Hope for Knee Osteoarthritis2025-08-28T10:31:00+08:00

Stem Cell Therapy for Liver Cirrhosis: Unlocking the Potential of Mesenchymal Stem Cells in Restoring Liver Function and Immune Homeostasis

2025-08-19T22:22:17+08:00

Explore how mesenchymal stem cell therapy offers new hope for cirrhosis patients, with 88.9% improvement rates in clinical trials. Learn about mechanisms, MX1⁺ monocyte reprogramming, and immunomodulatory effects.

Stem Cell Therapy for Liver Cirrhosis: Unlocking the Potential of Mesenchymal Stem Cells in Restoring Liver Function and Immune Homeostasis2025-08-19T22:22:17+08:00

Blood to Potential: Chemical Reprogramming Unlocks a New Era in Regenerative Medicine

2025-08-15T11:32:00+08:00

Discover how chemical reprogramming transforms human blood cells into pluripotent stem cells (hCiPS): breakthrough technology by Deng Hongkui's team, clinical advantages over genetic methods, and its revolutionary impact on regenerative medicine.

Blood to Potential: Chemical Reprogramming Unlocks a New Era in Regenerative Medicine2025-08-15T11:32:00+08:00

Raguneprocel: A New Dawn in Regenerative Medicine for Parkinson’s Disease

2025-08-13T20:00:29+08:00

Explore Raguneprocel – a revolutionary iPSC therapy for Parkinson's disease. Discover how donor-derived dopamine neurons restore motor function, its clinical trial breakthroughs, and advantages over traditional treatments

Raguneprocel: A New Dawn in Regenerative Medicine for Parkinson’s Disease2025-08-13T20:00:29+08:00
Go to Top